Literature DB >> 24548561

The Angiomotins--from discovery to function.

Susana Moleirinho1, William Guerrant1, Joseph L Kissil2.   

Abstract

Angiomotins were originally identified as angiostatin binding proteins and implicated in the regulation of endothelial cell migration. Recent studies have shed light on the role of Angiomotins and other members of the Motin protein family in epithelial cells and in pathways directly linked to the pathogenesis of cancer. In particular, Motins have been shown to play a role in signaling pathways regulated by small G-proteins and the Hippo-YAP pathway. In this review the role of the Motin protein family in these signaling pathways will be described and open questions will be discussed.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiomotin; Angiomotin-like 1; Angiomotin-like 2; Hippo; Merlin; Motin; NF2; YAP

Mesh:

Substances:

Year:  2014        PMID: 24548561      PMCID: PMC4112001          DOI: 10.1016/j.febslet.2014.02.006

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  96 in total

1.  The adaptor protein AMOT promotes the proliferation of mammary epithelial cells via the prolonged activation of the extracellular signal-regulated kinases.

Authors:  William P Ranahan; Zhang Han; Whitney Smith-Kinnaman; Sarah C Nabinger; Brigitte Heller; Britney-Shea Herbert; Rebecca Chan; Clark D Wells
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

2.  KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.

Authors:  S Moleirinho; N Chang; A H Sims; A M Tilston-Lünel; L Angus; A Steele; V Boswell; S C Barnett; C Ormandy; D Faratian; F J Gunn-Moore; P A Reynolds
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

3.  Identification and characterization of a novel tight junction-associated family of proteins that interacts with a WW domain of MAGI-1.

Authors:  Kevin M Patrie
Journal:  Biochim Biophys Acta       Date:  2005-08-15

4.  Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.

Authors:  Oriol Casanovas; Daniel J Hicklin; Gabriele Bergers; Douglas Hanahan
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

5.  YAP1 increases organ size and expands undifferentiated progenitor cells.

Authors:  Fernando D Camargo; Sumita Gokhale; Jonathan B Johnnidis; Dongdong Fu; George W Bell; Rudolf Jaenisch; Thijn R Brummelkamp
Journal:  Curr Biol       Date:  2007-11-01       Impact factor: 10.834

6.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

Authors:  Dawang Zhou; Claudius Conrad; Fan Xia; Ji-Sun Park; Bernhard Payer; Yi Yin; Gregory Y Lauwers; Wolfgang Thasler; Jeannie T Lee; Joseph Avruch; Nabeel Bardeesy
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

7.  Angiomotin regulates endothelial cell migration during embryonic angiogenesis.

Authors:  Karin Aase; Mira Ernkvist; Lwaki Ebarasi; Lars Jakobsson; Arindam Majumdar; Chunling Yi; Olivier Birot; Yue Ming; Anders Kvanta; Dan Edholm; Pontus Aspenström; Joseph Kissil; Lena Claesson-Welsh; Akihiko Shimono; Lars Holmgren
Journal:  Genes Dev       Date:  2007-08-15       Impact factor: 11.361

8.  Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.

Authors:  Mitsunori Ota; Hiroshi Sasaki
Journal:  Development       Date:  2008-11-12       Impact factor: 6.868

9.  YAP1 recruits c-Abl to protect angiomotin-like 1 from Nedd4-mediated degradation.

Authors:  Kassiani Skouloudaki; Gerd Walz
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

10.  In vivo analysis of Yorkie phosphorylation sites.

Authors:  H Oh; K D Irvine
Journal:  Oncogene       Date:  2009-03-30       Impact factor: 9.867

View more
  54 in total

1.  Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis.

Authors:  Beiyun Zhou; Per Flodby; Jiao Luo; Dan R Castillo; Yixin Liu; Fa-Xing Yu; Alicia McConnell; Bino Varghese; Guanglei Li; Nyam-Osor Chimge; Mitsuhiro Sunohara; Michael N Koss; Wafaa Elatre; Peter Conti; Janice M Liebler; Chenchen Yang; Crystal N Marconett; Ite A Laird-Offringa; Parviz Minoo; Kunliang Guan; Barry R Stripp; Edward D Crandall; Zea Borok
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

2.  Substrate rigidity-dependent positive feedback regulation between YAP and ROCK2.

Authors:  Wataru Sugimoto; Katsuhiko Itoh; Yasumasa Mitsui; Takahiro Ebata; Hideaki Fujita; Hiroaki Hirata; Keiko Kawauchi
Journal:  Cell Adh Migr       Date:  2018-01-29       Impact factor: 3.405

Review 3.  Cell Junctions in Hippo Signaling.

Authors:  Ruchan Karaman; Georg Halder
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 4.  The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.

Authors:  Manami Kodaka; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2014-09-30       Impact factor: 9.261

Review 5.  Tyrosine phosphorylation of WW proteins.

Authors:  Nina Reuven; Matan Shanzer; Yosef Shaul
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-26

6.  Actomyosin-Mediated Tension Orchestrates Uncoupled Respiration in Adipose Tissues.

Authors:  Kevin M Tharp; Michael S Kang; Greg A Timblin; Jon Dempersmier; Garret E Dempsey; Peter-James H Zushin; Jaime Benavides; Catherine Choi; Catherine X Li; Amit K Jha; Shingo Kajimura; Kevin E Healy; Hei Sook Sul; Kaoru Saijo; Sanjay Kumar; Andreas Stahl
Journal:  Cell Metab       Date:  2018-03-06       Impact factor: 27.287

Review 7.  Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway.

Authors:  Ursula Ehmer; Julien Sage
Journal:  Mol Cancer Res       Date:  2015-10-02       Impact factor: 5.852

8.  Angiomotin regulates budding and spread of Ebola virus.

Authors:  Ziying Han; Gordon Ruthel; Shantoshini Dash; Corbett T Berry; Bruce D Freedman; Ronald N Harty; Olena Shtanko
Journal:  J Biol Chem       Date:  2020-05-07       Impact factor: 5.157

9.  Angiomotin-like 2 interacts with and negatively regulates AKT.

Authors:  H Han; B Yang; W Wang
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

10.  Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression.

Authors:  Y-L Hsu; J-Y Hung; S-H Chou; M-S Huang; M-J Tsai; Y-S Lin; S-Y Chiang; Y-W Ho; C-Y Wu; P-L Kuo
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.